Skip to main content
Clinical Trials/NCT02601755
NCT02601755CompletedNot Applicable

iCanCope With Pain: An Integrated Smartphone and Web Self-management Program for Adolescents and Young Adults With Chronic Pain

The Hospital for Sick Children14 sites in 1 country302 target enrollmentStarted: April 1, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
302
Locations
14
Primary Endpoint
Intervention fidelity

Study Overview

Brief Summary

Chronic pain in adolescents and young adults (AYA, aged 15-25) is a common problem. Pain that is not treated properly can reduce quality of life. Programs to help AYA learn to live with and manage pain are very important. Our team is developing a smartphone application (app) and website for AYA with chronic pain. The app will help AYA to track pain, sleep, mood, activities, and exercise and help AYA set and achieve goals. The website will give information about pain and how to manage it independently. We will build the program and make sure it is easy to use and understand. We will also test if the program can be put into practice as planned and if AYA using the program feel less pain, have less limitations, and a better quality of life.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Participant)

Eligibility Criteria

Ages
15 Years to 25 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Diagnosed with chronic pain of at least 3 months duration according to medical chart
  • Able to speak and read English
  • Willing and able to complete online measures
  • Participants are active patients at pain clinic at one of the respective participating study sites
  • Have been on a stable dose of medications for at least 4 weeks prior to entering the study according to medical chart
  • Have access to an Internet-connected computer according to self-report.

Exclusion Criteria

  • Moderate to severe cognitive impairments, as assessed by reviewing medical chart and consultation with the patient's healthcare provider
  • Major co-morbid psychiatric (e.g. conversion disorder, depression, anxiety disorder) illness that may impact patient's ability to understand and use the iCanCope with Pain intervention via self-report, as determined by their health care provider
  • Patient from the department of haemology/oncology
  • Participated in the Phase 2B iCanCope usability study

Arms & Interventions

iCanCope app and website

Experimental

Intervention: Behavioral: iCanCope app and website

Intervention: iCanCope app and website (Behavioral)

Attention control group

Active Comparator

Intervention: Behavioral: Attention control group

Intervention: Attention control group (Behavioral)

Outcomes

Primary Outcomes

Intervention fidelity

Time Frame: 8 weeks

Any issues or difficulties encountered during implementation of the intervention, control strategy, or outcome measures will be tracked throughout the study by the CRPC.

Acceptability and Satisfaction

Time Frame: 8 weeks

Participants in the intervention arm will complete the Acceptability e-scale (AES) post-intervention. In addition, a subset of participants from the intervention group will be offered to participate in a qualitative feedback interview to further explore acceptability and satisfaction of the intervention.

Engagement with Intervention

Time Frame: 8 weeks

Google Analytics will track patterns of app and website usage.

Adherence

Time Frame: 8 weeks

Adherence will be determined using Google Analytics.

Participant Accrual and Dropout Rates

Time Frame: 8 weeks

This will be centrally tracked by the clinical research project coordinator (CRPC).

Participant Accrual and Dropout Rates

Time Frame: 6 months

This will be centrally tracked by the clinical research project coordinator (CRPC).

Secondary Outcomes

  • Pain intensity and interference(8 weeks)
  • Self-efficacy(8 weeks)
  • Emotional Functioning(8 weeks)
  • Sleep Functioning(8 weeks)
  • Social Functioning(8 weeks)
  • Pain-Related Knowledge(8 weeks)
  • Patients' Global Impression of Change(8 weeks)
  • Health-Related Quality of Life(8 weeks)
  • Health Care Utilization(8 weeks)
  • Adverse effects(8 weeks)
  • Pain intensity and interference(6 months)
  • Self-efficacy(6 months)
  • Emotional Functioning(6 months)
  • Sleep Functioning(6 months)
  • Social Functioning(6 months)
  • Health-Related Quality of Life(6 months)
  • Patients' Global Impression of Change(6 months)
  • Pain-Related Knowledge(6 months)
  • Health Care Utilization(6 months)
  • Adverse effects(6 months)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jennifer Stinson

Clinician Scientist, Clinical Nurse Specialist/NP

The Hospital for Sick Children

Study Sites (14)

Loading locations...

Similar Trials